(Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -126.72%-3.94M | -149.91%-1.32M | -0.48%12.2M | -48.97%4.12M | 974.76%7.18M | -131.57%-1.74M | 628.59%2.64M | 12.26M | 8.08M | -820.6K |
Net income from continuing operations | 17.47%-2.84M | -90.68%190.42K | -58,279.41%-4.76M | -330.83%-7.47M | 1,396.24%4.11M | -372.66%-3.44M | 162.51%2.04M | ---8.15K | ---1.73M | ---316.79K |
Operating gains losses | 120.57%8.18K | -21,228.66%-884.07K | 2,051.51%2.12M | 341.15%2.12M | 107.13%45.45K | -256.19%-39.76K | -118.56%-4.15K | ---108.76K | --480.78K | ---637.33K |
Depreciation and amortization | -123.00%-826.64K | 122.04%836.34K | 105.38%5.66M | 56.91%2.68M | 808.73%2.97M | -171.11%-370.69K | 89.72%376.66K | --2.76M | --1.71M | --327.17K |
Asset impairment expenditure | ---- | ---- | 427.34%7.63M | 338.75%7.37M | ---- | ---- | ---- | --1.45M | --1.68M | ---233.42K |
Remuneration paid in stock | 290.98%26.14K | 2,259.34%26.4K | -83.09%70.47K | -93.50%26.72K | 2,883.40%35.95K | 41.05%6.69K | --1.12K | --416.75K | --410.81K | --1.21K |
Other non cashItems | 116.30%206.58K | -44.40%92.12K | 314.53%900.09K | 410.67%638.99K | -100.04%-105 | -46.16%95.51K | 1,064.10%165.7K | --217.14K | ---205.68K | --262.61K |
Change In working capital | -125.15%-507.19K | -3,074.19%-1.58M | -92.35%577.17K | -121.83%-1.25M | -7.15%-240.05K | -42.49%2.02M | 103.58%53K | --7.54M | --5.74M | ---224.04K |
-Change in receivables | -95.44%89.77K | 37.03%-806.01K | 160.15%3.5M | 268.30%2.43M | -63.13%386.85K | 152.96%1.97M | 25.40%-1.28M | ---5.82M | ---1.44M | --1.05M |
-Change in inventory | -155.62%-8.03K | 176.19%8.03K | -110.32%-8.56K | -169.46%-1.87K | -19.03%-10.59K | -76.39%14.44K | -137.65%-10.54K | --82.94K | --2.69K | ---8.9K |
-Change in prepaid assets | 176.51%53.53K | 244.31%137.01K | -92.43%-1.33M | -339.13%-703.05K | -140.61%-460.64K | 95.30%-69.97K | 46.11%-94.94K | ---690.43K | ---160.1K | --1.13M |
-Change in payables and accrued expense | 63.41%-641.36K | -131.92%-999.2K | -116.64%-2.16M | -148.69%-4.13M | 115.68%590.6K | -121.42%-1.75M | 3,268.67%3.13M | --12.99M | --8.48M | ---3.77M |
-Change in other current assets | ---- | --0 | ---- | ---- | ---- | ---- | ---1.79M | ---- | ---- | ---- |
-Change in other working capital | -101.52%-1.1K | -10.21%83.76K | -41.37%573.5K | 200.81%1.15M | -154.52%-746.26K | -84.46%72.12K | -67.89%93.28K | --978.13K | ---1.15M | --1.37M |
Cash from discontinued investing activities | 56.44%6.16M | 121.49%336.16K | 22.00%-171.37K | 3.94M | -1.56M | -219.7K | ||||
Operating cash flow | 1.02%2.22M | -191.43%-979.04K | -0.09%12.03M | -49.73%3.95M | 685.64%4.81M | -59.97%2.2M | 314.78%1.07M | --12.04M | --7.86M | ---820.6K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -84.29%160.66K | 4.43%-1M | -0.13%-15.05M | 44.08%-4.75M | -1,478.73%-10.28M | 117.37%1.02M | -33,885.03%-1.05M | -15.04M | -8.49M | -650.98K |
Net PPE purchase and sale | --0 | --0 | 26.89%-57.16K | 69.13%-12.29K | 46.30%-16.83K | -213.68%-12.36K | -407.18%-15.68K | ---78.18K | ---39.8K | ---31.34K |
Net intangibles purchas and sale | ---- | 77.87%-229.12K | -0.86%-14.94M | 79.76%-1.91M | ---- | ---- | ---1.04M | ---14.81M | ---9.43M | --500.11K |
Net business purchase and sale | ---- | ---775.18K | --0 | ---- | ---- | ---- | --0 | --5.66K | ---- | ---- |
Net other investing changes | ---- | ---- | 60.35%-60.68K | -392.62%-2.83M | ---- | ---- | ---- | ---153.03K | --966.72K | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -51.46%-4.16M | 4.43%-1M | -0.13%-15.05M | 44.08%-4.75M | -900.06%-6.51M | 53.39%-2.74M | -33,885.03%-1.05M | ---15.04M | ---8.49M | ---650.98K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 101.99%36.71K | -3.82%-103.96K | -69.77%1.42M | 287.65%1.78M | 40.06%1.59M | -160.74%-1.85M | -273.45%-100.13K | 4.69M | 458.5K | 1.13M |
Net issuance payments of debt | 101.99%36.71K | -3.82%-103.96K | -69.77%1.42M | 323.46%1.78M | 40.06%1.59M | -159.86%-1.85M | -292.31%-100.13K | --4.69M | --419.72K | --1.13M |
Net common stock issuance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---41 |
Cash from discontinued financing activities | 278.40%1.15M | 140.55%493.02K | 39.44%-9.5K | -643.07K | 204.96K | -15.69K | ||||
Financing cash flow | 147.57%1.18M | 271.14%389.07K | -69.87%1.41M | 299.24%1.77M | 78.77%2.02M | -181.90%-2.49M | 81.60%104.83K | --4.67M | --442.81K | --1.13M |
Net cash flow | ||||||||||
Beginning cash position | -55.33%694.29K | -37.94%2.48M | 109.54%4M | -53.66%1.45M | -66.08%1.12M | 10.48%1.55M | 109.54%4M | --1.91M | --3.13M | --3.31M |
Current changes in cash | -3,166.30%-748.67K | 45.61%-1.59M | -196.43%-1.62M | 612.76%970.82K | 193.89%318.96K | -99.08%24.42K | -560.32%-2.93M | --1.68M | ---189.33K | ---339.73K |
Effect of exchange rate changes | 161.22%279.99K | -138.88%-190.73K | -75.37%101.31K | -94.35%59.86K | -94.84%8.22K | 39.07%-457.36K | 979.27%490.6K | --411.41K | --1.06M | --159.22K |
End cash Position | -79.88%225.61K | -55.33%694.29K | -37.94%2.48M | -37.94%2.48M | -53.66%1.45M | -66.08%1.12M | 10.48%1.55M | --4M | --4M | --3.13M |
Free cash from | -23.92%2.45M | -6,146.51%-1.21M | -4.10%-2.96M | 226.63%2.03M | -2,241.94%-8.24M | 929.00%3.22M | 103.98%19.98K | ---2.85M | ---1.6M | ---351.83K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.